EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway

Feiyan Cheng, Jingyuan Wang, Rongli Wang, Rumeng Pan, Zhiwei Cui, Lijun Wang, Lihui Wang, Xinyuan Yang

Molecular and Cellular Endocrinology · 2024

DOI: 10.1016/j.mce.2024.112248 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2024. Verfasst von Feiyan Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Fibroblast Growth Factor 2, Granulosa Cells, Cell Proliferation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Young women undergoing anticancer treatment are at risk of premature ovarian failure (POF). Endometrial-derived stem cells (EnSCs) have demonstrated significant therapeutic potential for treating ovarian insufficiency, although the underlying mechanisms remain to be fully understood. This study aims to further investigate the therapeutic effects of EnSCs, particularly through the paracrine action of fibroblast growth factor 2 (FGF2), on POF. The findings show that exogenous FGF2 enhances the survival of ovarian granulosa cells damaged by cisplatin. FGF2 stimulates the proliferation of these damaged cells by suppressing the Hippo signaling pathway and activating YAP expression. In vivo experiments also revealed that FGF2 treatment significantly improves ovarian reserve and endocrine function in mice with POF. These results suggest that FGF2 can boost the proliferative capacity of damaged ovarian granulosa cells through the Hippo-YAP signaling pathway, providing a theoretical foundation for using EnSCs and FGF2 in clinical treatments for POF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Ovarian InsufficiencyFibroblast Growth Factor 2Granulosa CellsCell ProliferationSignal TransductionHippo Signaling PathwayYAP-Signaling ProteinsFemaleAnimalsHumansMiceProtein Serine-Threonine KinasesTranscription FactorsCisplatinAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

FGF2Hippo-YAP signaling pathwayPOFProliferation

Substanzen

Fibroblast Growth Factor 2YAP-Signaling ProteinsProtein Serine-Threonine KinasesTranscription FactorsYap1 protein, mouseCisplatinAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Department of Clinical Laboratory, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China.
  • Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, PR China. Electronic address: yxy19752023@163.com.

Zitieren

APA

Cheng, F., Wang, J., Wang, R., Pan, R., Cui, Z., Wang, L., Wang, L., & Yang, X. (2024). FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2024.112248

Vancouver

Cheng F, Wang J, Wang R, Pan R, Cui Z, Wang L, et al. FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway. Molecular and Cellular Endocrinology. 2024. doi:10.1016/j.mce.2024.112248

BibTeX
@article{Cheng2024,
  author = {Cheng, Feiyan and Wang, Jingyuan and Wang, Rongli and Pan, Rumeng and Cui, Zhiwei and Wang, Lijun and Wang, Lihui and Yang, Xinyuan},
  title = {FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway},
  journal = {Molecular and Cellular Endocrinology},
  year = {2024},
  doi = {10.1016/j.mce.2024.112248}
}
Kostenlos starten →